N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli

(2017) Daning Wang et al.   PROTEIN EXPRESSION AND PURIFICATION

Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site

(2017) Jian Guan et al.   STRUCTURE

Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine

(2017) Ying Gu et al.   VACCINE

Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity

(2017) Huirong Pan et al.   VACCINE

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction

(2016) Zhihai Li et al.   STRUCTURE

Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody

(2015) Ying Gu et al.   CELL RESEARCH

Evaluation of tributyltin toxicity in Chinese rare minnow larvae by abnormal behavior, energy metabolism and endoplasmic reticulum stress

(2015) Zhi-Hua Li et al.   CHEMICO-BIOLOGICAL INTERACTIONS

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls

(2015) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin®

(2014) Xiao Zhang et al.   VACCINE

Cross-roads in the classification of papillomaviruses

(2013) Ethel-Michele de Villiers   VIROLOGY

Diseases associated with human papillomavirus infection

(2013) Heather A. Cubie   VIROLOGY

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy

(2013) Qinjian Zhao et al.   Human Vaccines & Immunotherapeutics

RELION: Implementation of a Bayesian approach to cryo-EM structure determination

(2012) Sjors H.W. Scheres   JOURNAL OF STRUCTURAL BIOLOGY

Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity

(2012) Yixin Chen et al.   VACCINE

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

(2012) Beatriz Serrano et al.   Infectious Agents and Cancer

Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles

(2011) N. Hanumantha Rao et al.   VACCINE

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

(2010) Michel Deschuyteneer et al.   Human vaccines & immunotherapeutics

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Subunit interactions in bovine papillomavirus

(2010) M. Wolf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity

(2009) L. Schadlich et al.   JOURNAL OF VIROLOGY

Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity

(2009) Lysann Schädlich et al.   VACCINE

Enhanced papillomavirus-like particle production in insect cells

(2009) Tilo Senger et al.   VIROLOGY

A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response

(2008) N. Thones et al.   JOURNAL OF VIROLOGY

Arrangement of L2 within the Papillomavirus Capsid

(2008) C. B. Buck et al.   JOURNAL OF VIROLOGY

Packaging of a Polymer by a Viral Capsid: The Interplay between Polymer Length and Capsid Size

(2007) Yufang Hu et al.   BIOPHYSICAL JOURNAL